The TLR3 agonist poly(I:C) targets CD8+ T cells and augments their antigen-specific responses upon their adoptive transfer into naïve recipient mice
about
Immune Adjuvant Effect of Molecularly-defined Toll-Like Receptor LigandsAttenuation of the influenza virus sickness behavior in mice deficient in Toll-like receptor 3Cyclophosphamide induces bone marrow to yield higher numbers of precursor dendritic cells in vitro capable of functional antigen presentation to T cells in vivo.Systemic administration of TLR3 agonist induces IL-7 expression and IL-7-dependent CXCR3 ligand production in the lung.Poly-ICLC promotes the infiltration of effector T cells into intracranial gliomas via induction of CXCL10 in IFN-alpha and IFN-gamma dependent mannersMapping quantitative trait loci for T lymphocyte subpopulations in peripheral blood in swine.Immunomodulatory effects of dsRNA and its potential as vaccine adjuvant.Prevention of airway allograft tolerance by polyinosinic:polycytidylic acid requires type I interferon responsiveness for mouse airway obliterationTLR agonists: our best frenemy in cancer immunotherapyInterferon regulatory factor 3 controls interleukin-17 expression in CD8 T lymphocytes.Functions of invariant NK T cells are modulated by TLR ligands and IFN-α.Total Leishmania antigens with Poly(I:C) induce Th1 protective response.Poly (I:C) enhances the anti-tumor activity of canine parvovirus NS1 protein by inducing a potent anti-tumor immune response.Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy.Characterization and expression of Cd8 molecules in mandarin fish Siniperca chuatsi.Immunogenicity of a Fully Synthetic MUC1 Glycopeptide Antitumor Vaccine Enhanced by Poly(I:C) as a TLR3-Activating Adjuvant.
P2860
Q28972540-61B80291-A981-4FAA-B4D1-5B9CB29B0ED8Q33637378-65FCB63A-0069-4EFD-A921-F057748D954AQ33653210-76FD5DE4-80B9-4112-9C25-087287564EF7Q33730296-F9412974-9E52-4968-B160-DA6895F71513Q33945653-24ED1F64-D935-4409-90EC-368DEB7C4B94Q34020900-4602B39F-EC46-42D0-BD98-754C9D92ECB0Q34022013-168633B6-EE86-4C62-A433-6E587F92DA96Q34372089-A43FAB96-CCCE-48DF-817C-7FC77C9A5552Q36850457-CE0E7243-2C7E-46EA-9DE5-3939BFF507FDQ37117776-A88830E3-FEA0-452B-BE09-1A4E11303A07Q38984210-6A6E1DAB-CCB5-406F-982D-5C48DB753F2CQ40049613-E00B6B39-D456-48BE-9053-54ABDEE3BA3BQ40516283-3E3775B4-2A3E-4F2B-9345-DAC9F289596AQ42378527-ADB4CFAE-AC98-47F4-A881-BF8AC089F47DQ44732359-086F311F-0734-4A97-853F-D4F4815C9AA8Q51036586-986B2409-A2D8-4EDB-9A4C-F30880B2D5DF
P2860
The TLR3 agonist poly(I:C) targets CD8+ T cells and augments their antigen-specific responses upon their adoptive transfer into naïve recipient mice
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
The TLR3 agonist poly
@nl
The TLR3 agonist poly(I:C) tar ...... sfer into naïve recipient mice
@ast
The TLR3 agonist poly(I:C) tar ...... sfer into naïve recipient mice
@en
type
label
The TLR3 agonist poly
@nl
The TLR3 agonist poly(I:C) tar ...... sfer into naïve recipient mice
@ast
The TLR3 agonist poly(I:C) tar ...... sfer into naïve recipient mice
@en
prefLabel
The TLR3 agonist poly
@nl
The TLR3 agonist poly(I:C) tar ...... sfer into naïve recipient mice
@ast
The TLR3 agonist poly(I:C) tar ...... sfer into naïve recipient mice
@en
P2093
P2860
P1433
P1476
The TLR3 agonist poly(I:C) tar ...... sfer into naïve recipient mice
@en
P2093
C Marcela Diaz-Montero
David J Cole
Mohamed L Salem
Omar Moussa
Sabry A El-Naggar
P2860
P304
P356
10.1016/J.VACCINE.2008.11.013
P407
P577
2008-11-21T00:00:00Z